Patent details

EP2342233 Title: ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP2342233
PCT Application Number:
PCT/EP/2009/062787
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097446454
PCT Publication Number:
WO/2010/037831
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
French Title of Invention:
ANTICORPS ANTI CXCR4 ET LEUR UTILISATION DANS LE TRAITEMENT CONTRE LE CANCER
German Title of Invention:
ANTI-CXCR4-ANTIKÖRPER UND IHRE VERWENDUNG BEI DER KREBSBEHANDLUNG
SPC Number:

Dates

Filing date:
01/10/2009
Grant date:
25/06/2014
EP Publication Date:
25/06/2014
PCT Publication Date:
08/04/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/07/2011
EP B1 Publication Date:
25/06/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/10/2016
Expiration date:
01/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/10/2009
 
 

Name:
Pierre Fabre Médicament
Address:
45, Place Abel Gance, 92100 Boulogne-Billancourt, France (FR)

Agent

Name:
REGIMBEAU
From:
10/09/2014
Address:
RUE DE CHAZELLES 20, 75847, PARIS CEDEX 17, France (FR)
To:

Inventor

1

Name:
KLINGUER-HAMOUR Christine
Address:
France (FR)

2

Name:
GRENIR-CAUSSANEL Véronique
Address:
France (FR)

Priority

1

Priority Number:
136772 P
Priority Date:
28/05/1999
Priority Country:
United States (US)

2

Priority Number:
08305631
Priority Date:
01/10/2008
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
173743 P
Priority Date:
29/04/2009
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/09/2015
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
ACUMASS SARL
Filing date Document type Number of pages